Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (171-180 of 231) with videos related to

Pageof 24
Sort By:
Autoimmunity Reviews|February 17, 2020
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patientsMatteo Garibaldi, Laura Fionda, Fiammetta Vanoli, et al.
Journal of Neurology|January 26, 2021
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosisMatteo Lucchini, Luca Prosperini, Maria Chiara Buscarinu, et al.
Brain : a Journal of Neurology|July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosisSofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Frontiers in Neurology|September 13, 2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With DimethylfumarateMaria C Buscarinu, Francesca Gargano, Luana Lionetto, et al.
Metabolism: Clinical and Experimental|November 15, 2017
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respirationClaudia La Rocca, Fortunata Carbone, Veronica De Rosa, et al.
Neuromuscular Disorders : NMD|January 1, 2021
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark coresMatteo Garibaldi, Fabiana Fattori, Elena Maria Pennisi, et al.
Nature Immunology|September 29, 2015
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variantsVeronica De Rosa, Mario Galgani, Antonio Porcellini, et al.
Journal of the Peripheral Nervous System : JPNS|August 3, 2023
Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)Luca Leonardi, Rocco Costanzo, Francesca Forcina, et al.
Multiple Sclerosis and Related Disorders|March 11, 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observationViola Baione, Marco Canevelli, Daniele Belvisi, et al.
Clinical & Translational Immunology|March 27, 2023
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipientsMartina Severa, Fabiana Rizzo, Alessandro Sinigaglia, et al.
Pageof 24

Showing results (171-180 of 231) with videos related to

Sort By:
Pageof 24
Autoimmunity Reviews|February 17, 2020
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patientsMatteo Garibaldi, Laura Fionda, Fiammetta Vanoli, et al.
Journal of Neurology|January 26, 2021
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosisMatteo Lucchini, Luca Prosperini, Maria Chiara Buscarinu, et al.
Brain : a Journal of Neurology|July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosisSofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Frontiers in Neurology|September 13, 2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With DimethylfumarateMaria C Buscarinu, Francesca Gargano, Luana Lionetto, et al.
Metabolism: Clinical and Experimental|November 15, 2017
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respirationClaudia La Rocca, Fortunata Carbone, Veronica De Rosa, et al.
Neuromuscular Disorders : NMD|January 1, 2021
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark coresMatteo Garibaldi, Fabiana Fattori, Elena Maria Pennisi, et al.
Nature Immunology|September 29, 2015
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variantsVeronica De Rosa, Mario Galgani, Antonio Porcellini, et al.
Journal of the Peripheral Nervous System : JPNS|August 3, 2023
Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)Luca Leonardi, Rocco Costanzo, Francesca Forcina, et al.
Multiple Sclerosis and Related Disorders|March 11, 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observationViola Baione, Marco Canevelli, Daniele Belvisi, et al.
Clinical & Translational Immunology|March 27, 2023
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipientsMartina Severa, Fabiana Rizzo, Alessandro Sinigaglia, et al.
Pageof 24